A1 adenosine receptors mediate hypoxia-induced ventriculomegaly.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMC 208824)

Published in Proc Natl Acad Sci U S A on September 15, 2003

Authors

Christopher P Turner1, Meltem Seli, Laura Ment, William Stewart, Henglin Yan, Bjorn Johansson, Bertil B Fredholm, Michael Blackburn, Scott A Rivkees

Author Affiliations

1: Department of Pediatrics, Yale University School of Medicine, New Haven, CT 06520, USA.

Articles citing this

Adenosine receptors as therapeutic targets. Nat Rev Drug Discov (2006) 6.15

Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74

How I treat ADA deficiency. Blood (2009) 1.70

Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. Purinergic Signal (2005) 1.58

Fgfr1 is required for cortical regeneration and repair after perinatal hypoxia. J Neurosci (2009) 1.28

Release of adenosine and ATP during ischemia and epilepsy. Curr Neuropharmacol (2009) 1.21

Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol (2009) 1.08

Cortical glial fibrillary acidic protein-positive cells generate neurons after perinatal hypoxic injury. J Neurosci (2011) 1.07

A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. Proc Natl Acad Sci U S A (2007) 1.02

Pathophysiology of glia in perinatal white matter injury. Glia (2014) 1.00

Hypoxic injury during neonatal development in murine brain: correlation between in vivo DTI findings and behavioral assessment. Cereb Cortex (2009) 1.00

Sex differences in a hypoxia model of preterm brain damage. Pediatr Res (2009) 0.95

Measurement of purine release with microelectrode biosensors. Purinergic Signal (2011) 0.92

Embryonic caffeine exposure induces adverse effects in adulthood. FASEB J (2008) 0.90

Adverse and protective influences of adenosine on the newborn and embryo: implications for preterm white matter injury and embryo protection. Pediatr Res (2011) 0.89

Diazoxide promotes oligodendrocyte precursor cell proliferation and myelination. PLoS One (2010) 0.89

Mouse intermittent hypoxia mimicking apnoea of prematurity: effects on myelinogenesis and axonal maturation. J Pathol (2011) 0.89

Embryonic caffeine exposure acts via A1 adenosine receptors to alter adult cardiac function and DNA methylation in mice. PLoS One (2014) 0.87

Caffeine therapy in preterm infants. World J Clin Pediatr (2015) 0.87

Regulation of cerebrospinal fluid production by caffeine consumption. BMC Neurosci (2009) 0.84

Identification of the heart as the critical site of adenosine mediated embryo protection. BMC Dev Biol (2010) 0.84

Roles of white matter in central nervous system pathophysiologies. ASN Neuro (2012) 0.83

Regulation of cardiovascular development by adenosine and adenosine-mediated embryo protection. Arterioscler Thromb Vasc Biol (2012) 0.83

Role of adenosine in oligodendrocyte precursor maturation. Front Cell Neurosci (2015) 0.79

Caffeine acts via A1 adenosine receptors to disrupt embryonic cardiac function. PLoS One (2011) 0.79

Differential expression of adenosine A1 and A2A receptors after upper cervical (C2) spinal cord hemisection in adult rats. J Spinal Cord Med (2007) 0.78

Therapeutic effect of caffeine treatment immediately following neonatal hypoxic-ischemic injury on spatial memory in male rats. Brain Sci (2013) 0.77

Abbreviated exposure to hypoxia is sufficient to induce CNS dysmyelination, modulate spinal motor neuron composition, and impair motor development in neonatal mice. PLoS One (2015) 0.75

Neuroprotective effects of adenosine deaminase in the striatum. J Cereb Blood Flow Metab (2016) 0.75

Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients. Sci Rep (2017) 0.75

A1 Adenosine Receptor Activation Modulates Central Nervous System Development and Repair. Mol Neurobiol (2016) 0.75

Articles cited by this

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 9.90

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev (1999) 6.26

Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res (2001) 3.88

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A (2001) 2.73

Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63

White matter disorders of prematurity: association with intraventricular hemorrhage and ventriculomegaly. The Developmental Epidemiology Network. J Pediatr (1999) 1.93

Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res (1999) 1.86

Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.69

Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol (1991) 1.68

Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J Biol Chem (1998) 1.64

Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics (2002) 1.59

Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res (2001) 1.59

Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endocrinol (1992) 1.55

White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Hum Dev (1998) 1.49

Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci (2002) 1.37

Adenosine A(2A) receptors are colocalized with and activate g(olf) in rat striatum. Mol Pharmacol (2000) 1.27

Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem (1987) 1.22

Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 1.16

Association of chronic sublethal hypoxia with ventriculomegaly in the developing rat brain. Brain Res Dev Brain Res (1998) 1.16

Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.12

Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. Teratology (1992) 1.09

Influences of adenosine on the fetus and newborn. Mol Genet Metab (2001) 1.03

The ontogeny of cardiac and neural A1 adenosine receptor expression in rats. Brain Res Dev Brain Res (1995) 1.00

Is periventricular leucomalacia a result of hypoxic-ischaemic injury? Hypocapnia and the preterm brain. Biol Neonate (2001) 0.98

Periventricular leukomalacia: relationship between lateral ventricular volume on brain MR images and severity of cognitive and motor impairment. Radiology (2000) 0.95

Treatment of apnea of prematurity. Paediatr Drugs (2003) 0.95

Are A3 adenosine receptors expressed in the brain? Neuroreport (2000) 0.95

A new model of white matter injury in neonatal rats with bilateral carotid artery occlusion. Brain Res (1999) 0.95

Adenosine A1 receptors are located predominantly on axons in the rat hippocampal formation. J Comp Neurol (1995) 0.95

The levels of adenosine and its metabolites in the guinea pig and rat brain during complete ischemia-in vivo study. Brain Res (1998) 0.90

Maternal caffeine intake has minor effects on adenosine receptor ontogeny in the rat brain. Pediatr Res (2000) 0.89

A1 adenosine receptor activation induces ventriculomegaly and white matter loss. Neuroreport (2002) 0.83

Neurodevelopmental outcome at 5-7 years in preterm infants with periventricular leukomalacia. Neuropediatrics (1994) 0.81

Articles by these authors

Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid (2011) 7.17

Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain (2013) 3.87

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract (2011) 3.40

Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol (2013) 2.84

Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr (2013) 2.71

It is (sort of) a boy and (sort of) a girl. You have (sort of) a say and you (sort of) don't? The uneasiness of genital restoration surgery. J Pediatr Endocrinol Metab (2006) 2.67

Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease? Nat Rev Neurosci (2010) 2.34

Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci (2005) 2.34

Axonal pathology in traumatic brain injury. Exp Neurol (2012) 2.20

Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal (2003) 2.19

Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology (2006) 2.19

Widespread τ and amyloid-β pathology many years after a single traumatic brain injury in humans. Brain Pathol (2011) 2.11

I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer. J Clin Endocrinol Metab (2011) 2.02

Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature (2002) 1.91

Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc Natl Acad Sci U S A (2002) 1.81

A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors. J Clin Invest (2011) 1.79

Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov (2013) 1.74

Putting propylthiouracil in perspective. J Clin Endocrinol Metab (2009) 1.73

American pediatric academia: the looming question. J Pediatr (2007) 1.66

Characterization and outcome of patients with severe symptomatic aortic stenosis referred for percutaneous aortic valve replacement. J Thorac Cardiovasc Surg (2009) 1.57

A descriptive analysis of an integrative medicine clinic. J Altern Complement Med (2004) 1.56

The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid (2009) 1.56

Recommendations for the use of palivizumab as prophylaxis against respiratory syncytial virus in infants with congenital cardiac disease. Cardiol Young (2003) 1.47

Protective effects of caffeine on chronic hypoxia-induced perinatal white matter injury. Ann Neurol (2006) 1.44

Sleep and its homeostatic regulation in mice lacking the adenosine A1 receptor. J Sleep Res (2003) 1.44

Single center TAVR experience with a focus on the prevention and management of catastrophic complications. Catheter Cardiovasc Interv (2014) 1.43

Ending propylthiouracil-induced liver failure in children. N Engl J Med (2009) 1.40

Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol (2006) 1.40

Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp Neurol (2006) 1.35

Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci (2011) 1.35

CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci (2011) 1.29

Emerging concepts in periventricular white matter injury. Semin Perinatol (2004) 1.27

Partial interruption of axonal transport due to microtubule breakage accounts for the formation of periodic varicosities after traumatic axonal injury. Exp Neurol (2011) 1.26

Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. J Orthop Res (2004) 1.25

Surgical repair of posterior mitral valve prolapse: implications for guidelines and percutaneous repair. Ann Thorac Surg (2010) 1.23

Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol (2007) 1.23

Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model. Ann Neurol (2014) 1.23

Executive and memory function in adolescents born very preterm. Pediatrics (2011) 1.22

Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a(1) receptors. J Pharmacol Exp Ther (2002) 1.22

Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol (2005) 1.17

The G(s)-coupled adenosine A(2B) receptor recruits divergent pathways to regulate ERK1/2 and p38. Exp Cell Res (2003) 1.17

Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain (2005) 1.16

Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc Natl Acad Sci U S A (2008) 1.15

Chromobacterium subtsugae sp. nov., a betaproteobacterium toxic to Colorado potato beetle and other insect pests. Int J Syst Evol Microbiol (2007) 1.15

Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg (2014) 1.15

Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Clin Cardiol (2013) 1.15

MRI evaluation and functional assessment of brain injury after hypoxic ischemia in neonatal mice. Stroke (2002) 1.13

Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice. Stroke (2003) 1.12

Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J (2010) 1.12

Repetitive mild traumatic brain injury in a mouse model produces learning and memory deficits accompanied by histological changes. J Neurotrauma (2012) 1.11

Adenosine and ATP receptors in the brain. Curr Top Med Chem (2011) 1.10

Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology (2010) 1.10

Modulation of glial cell functions by adenosine receptors. Physiol Behav (2007) 1.09

Reduction in intracellular calcium levels inhibits myoblast differentiation. J Biol Chem (2002) 1.09

Mice lacking the adenosine A1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur J Neurosci (2002) 1.08

Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Arthritis Rheum (2010) 1.08

Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol (2009) 1.08

Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons. J Neurosci (2005) 1.07

Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res (2002) 1.04

1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J Immunol (2007) 1.04

Microfluidic biosensing systems. Part II. Monitoring the dynamic production of glucose and ethanol from microchip-immobilised yeast cells using enzymatic chemiluminescent micro-biosensors. Lab Chip (2004) 1.03

Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin. Eur J Pharmacol (2008) 1.02

A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. Proc Natl Acad Sci U S A (2007) 1.02

LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). J Neuroimmunol (2009) 1.01

Influence of the adenosine A1 receptor on blood pressure regulation and renin release. Am J Physiol Regul Integr Comp Physiol (2005) 1.01

Evidence for functional adenosine A3 receptors in microglia cells. J Neurochem (2003) 1.01

Adenosine induces airway hyperresponsiveness through activation of A3 receptors on mast cells. J Allergy Clin Immunol (2008) 1.01

Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol (2002) 1.01

Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev Dyn (2003) 1.00

Toxic effects of cobalt in primary cultures of mouse astrocytes. Similarities with hypoxia and role of HIF-1alpha. Biochem Pharmacol (2006) 0.98

Sphingosine-1-phosphate inhibits cell migration and endothelial to mesenchymal cell transformation during cardiac development. Dev Biol (2006) 0.98

Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2. Mol Pharmacol (2002) 0.98

Differentiated thyroid cancer in children: diagnosis and management. Curr Opin Oncol (2008) 0.98

Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid (2013) 0.97

Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans. Acta Neuropathol (2011) 0.97

Photobactin: a catechol siderophore produced by Photorhabdus luminescens, an entomopathogen mutually associated with Heterorhabditis bacteriophora NC1 nematodes. Appl Environ Microbiol (2003) 0.96

Preterm deliveries that result from multiple pregnancies associated with assisted reproductive technologies in the USA: a cost analysis. Curr Opin Obstet Gynecol (2011) 0.96

Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage. Eur J Pharmacol (2008) 0.96

The adenosine A1 receptor contributes to the stimulatory, but not the inhibitory effect of caffeine on locomotion: a study in mice lacking adenosine A1 and/or A2A receptors. Neuropharmacology (2004) 0.96

Hypoxia-induced developmental delays of inhibitory interneurons are reversed by environmental enrichment in the postnatal mouse forebrain. J Neurosci (2013) 0.95

Susceptibility of the developing brain to acute hypoglycemia involving A1 adenosine receptor activation. Am J Physiol Endocrinol Metab (2005) 0.95

Neonatal hypoxia suppresses oligodendrocyte Nogo-A and increases axonal sprouting in a rodent model for human prematurity. Exp Neurol (2004) 0.95

The role of extracellular adenosine in regulating mossy fiber synaptic plasticity. J Neurosci (2005) 0.95

A neprilysin polymorphism and amyloid-beta plaques after traumatic brain injury. J Neurotrauma (2009) 0.94

Hypoglycemia influences oligodendrocyte development and myelin formation. Neuroreport (2006) 0.94

Deletion of the adenosine A1 receptor gene does not alter neuronal damage following ischaemia in vivo or in vitro. Eur J Neurosci (2004) 0.94

Binding of the prototypical adenosine A(2A) receptor agonist CGS 21680 to the cerebral cortex of adenosine A(1) and A(2A) receptor knockout mice. Br J Pharmacol (2004) 0.94

Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice. Eur Neuropsychopharmacol (2005) 0.94

Hypoxia alters cell cycle regulatory protein expression and induces premature maturation of oligodendrocyte precursor cells. PLoS One (2009) 0.93

Modeling the neurovascular niche: murine strain differences mimic the range of responses to chronic hypoxia in the premature newborn. J Neurosci Res (2008) 0.93

Blood-Brain Barrier Disruption Is an Early Event That May Persist for Many Years After Traumatic Brain Injury in Humans. J Neuropathol Exp Neurol (2015) 0.93

A1 receptor deficiency causes increased insulin and glucagon secretion in mice. Biochem Pharmacol (2007) 0.92

Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab (2003) 0.92

Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action. Biochem J (2004) 0.92

Mice heterozygous for both A1 and A(2A) adenosine receptor genes show similarities to mice given long-term caffeine. J Appl Physiol (1985) (2008) 0.92

Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors. Proc Natl Acad Sci U S A (2008) 0.92